Short-term tolerability and dose toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors (NET)

被引：0
|
作者：
Plaza, Bonilla J. [1 ]
Lorca, Martinez A. [1 ]
Martinez, Navarro T. [1 ]
Hernandez, Azpeitia P. [1 ]
Alonso-Gordoa, T. [1 ]
Molina-Cerrillo, J. [1 ]
Diez, Orduna M. D. P. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2022年 / 34卷
关键词：
prrt; 177lu; toxicity;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H04
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [21] Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE
    Roth, Daniel
    Gustafsson, Johan
    Warfvinge, Carl Fredrik
    Sundlov, Anna
    Akesson, Anna
    Tennvall, Jan
    Gleisner, Katarina Sjogreen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 399 - 405
  • [22] 177Lu-Dotatate Peptide Receptor Radionuclide Therapy Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, U. M. M.
    Ilan, E.
    Sandstrom, M.
    Bamerny, M.
    Garske-Roman, U.
    Lubberink, M.
    Sundin, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S157 - S158
  • [23] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
    Mitjavila Casanovas, M.
    Pubul, V.
    Bello, P.
    Miguel, B.
    Cano, J.
    Balaguer, D.
    Garcia-Burillo, A.
    Marino Mendez, A.
    Rodeno, E.
    Custodio, A.
    Pineiro, A.
    Garcia-Canamaque, L.
    Castellon, M.
    Orduna, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S103 - S104
  • [24] 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, Ulrika
    Ilan, Ezgi
    Sandstrom, Mattias
    Garske-Roman, Ulrike
    Lubberink, Mark
    Sundin, Anders
    NEUROENDOCRINOLOGY, 2020, 110 (7-8) : 662 - 670
  • [25] Spatiotemporal evolution of lesion response heterogeneity to 177Lu-DOTATATE therapy in advanced gastroenteropancreatic neuroendocrine tumors
    Perk, Timothy
    Yip, Stephen
    Jeraj, Robert
    Perlman, Scott
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [26] Radiological, clinical, scintigraphic and serum markers response of advanced neuroendocrine tumors treated with 177Lu-DOTATATE
    Mitjavila Casanovas, M.
    Percovich, J.
    Bello, P.
    Pubul, V.
    Arbizu, J.
    Muros, M.
    Garcia-Carbonero, R.
    Rotger, A.
    Gonzalez, E.
    Llana, B.
    Marin, M.
    Field, C.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S594 - S594
  • [27] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
    Zidan, Lamiaa
    Iravani, Amir
    Oleinikov, Kira
    Ben-Haim, Simona
    Gross, David J.
    Meirovitz, Amichay
    Maimon, Ophra
    Akhurst, Tim
    Michael, Michael
    Hicks, Rodney J.
    Grozinsky-Glasberg, Simona
    Kong, Grace
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (02) : 218 - 225
  • [28] Early prediction of the efficacy of 177Lu-DOTATATE in patients with metastatic neuroendocrine tumors
    Bando-Delaunay, A.
    de Rycke, O.
    Hentic, O.
    Leclerc, P.
    Allouch, A.
    Cros, J.
    Rebours, V
    Ruszniewski, P.
    Lebtahi, R.
    de Mestier, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 176 - 176
  • [29] A shared experience in the treatment of neuroendocrine tumors (NET) with 177 Lu dotatate
    Lobo, G.
    Veras, M.
    Gomes, G.
    Tinoco Mesquita, C.
    Magalhaes, J.
    Hungria, P.
    Ramos, R.
    Barlete, A.
    Santos, T.
    Sadeck, G.
    Ker, W.
    Lavatori, N.
    Cotrado, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S419 - S419
  • [30] Current Experience in Heavily Pretreated Metastatic Neuroendocrine Tumors (NET) Treated with 177Lu-DOTATATE (LU). A Single Institution Experience
    Saavedra, C.
    Gajate, P.
    Molina, J.
    Navarro, T.
    Martinez, A.
    Diez, J. J.
    Grande, E.
    Alonso, T.
    NEUROENDOCRINOLOGY, 2019, 108 : 230 - 230
12345